Here’s what else you need to know to Get Up to Speed and On with Your Day.

Moderna announced positive interim results from an early-stage trial of a vaccine that targeted bird flu virus.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

A new type of coronavirus vaccine administered nasally has proven effective when tested on animals, researchers at the ...

Department of Cancer Biology, The University of Kansas Medical Center, Cancer Center, Kansas City, Kansas 66160, United States Center of BioModular Multi-Scale Systems for Precision Medicine, The ...

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

On Friday evening, December 18, 2020 the United States Food & Drug Administration (FDA) approved Moderna’s mRNA Covid-19 vaccine for emergency use, joining Pfizer’s previously approved ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...

3 investigational HIV-1 trimer mRNA vaccines induced mild- to moderate-adverse effects in a phase 1, randomized trial. HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA ...

USA: A new phase 3 clinical trial has found that a single multi-component mRNA vaccine targeting both seasonal influenza and COVID-19 is not only well-tolerated but also produces immune responses on ...

How to contact Nature Biotechnology executives were elated. Trump had, just five years earlier, propelled mRNA medicines into the spotlight through his signature effort to fast-track the ...